Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Trends in Prevalence of Diabetes and Control of Risk Factors in Diabetes Among US Adults, 1999-2018
Li Wang, Xiaoguang Li, Zhaoxin Wang, et al.
JAMA (2021) Vol. 326, Iss. 8, pp. 704-704
Open Access | Times Cited: 393

Showing 1-25 of 393 citing articles:

Prevalence and Treatment of Diabetes in China, 2013-2018
Limin Wang, Wen Peng, Zhenping Zhao, et al.
JAMA (2021) Vol. 326, Iss. 24, pp. 2498-2498
Open Access | Times Cited: 592
Heart Failure: An Underappreciated Complication of Diabetes. A Consensus Report of the American Diabetes Association
Rodica Pop‐Busui, James L. Januzzi, Dennis Bruemmer, et al.
Diabetes Care (2022) Vol. 45, Iss. 7, pp. 1670-1690
Open Access | Times Cited: 221
Trends in Cardiovascular Risk Factors in US Adults by Race and Ethnicity and Socioeconomic Status, 1999-2018
Jiang He, Zhengbao Zhu, Joshua D. Bundy, et al.
JAMA (2021) Vol. 326, Iss. 13, pp. 1286-1286
Open Access | Times Cited: 184
Cardiovascular Risk Factor Prevalence, Treatment, and Control in US Adults Aged 20 to 44 Years, 2009 to March 2020
Rahul Aggarwal, Robert W. Yeh, Karen E. Joynt Maddox, et al.
JAMA (2023) Vol. 329, Iss. 11, pp. 899-899
Open Access | Times Cited: 135
Improving health outcomes of people with diabetes: target setting for the WHO Global Diabetes Compact
Edward W. Gregg, James Buckley, Mohammed K. Ali, et al.
The Lancet (2023) Vol. 401, Iss. 10384, pp. 1302-1312
Open Access | Times Cited: 124
Development and validation of a trans-ancestry polygenic risk score for type 2 diabetes in diverse populations
Tian Ge, Marguerite R. Irvin, Amit Patki, et al.
Genome Medicine (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 107
Variation in Population Attributable Fraction of Dementia Associated With Potentially Modifiable Risk Factors by Race and Ethnicity in the US
Mark Lee, Eric A. Whitsel, Christy L. Avery, et al.
JAMA Network Open (2022) Vol. 5, Iss. 7, pp. e2219672-e2219672
Open Access | Times Cited: 101
Prevalence of Diabetic Retinopathy in the US in 2021
Elizabeth A. Lundeen, Zeb Burke-Conte, David B. Rein, et al.
JAMA Ophthalmology (2023) Vol. 141, Iss. 8, pp. 747-747
Open Access | Times Cited: 99
National Trends in Use of Sodium‐Glucose Cotransporter‐2 Inhibitors and Glucagon‐like Peptide‐1 Receptor Agonists by Cardiologists and Other Specialties, 2015 to 2020
Rishav Adhikari, Kunal Jha, Zeina Dardari, et al.
Journal of the American Heart Association (2022) Vol. 11, Iss. 9
Open Access | Times Cited: 83
Longitudinal Trends in Glycemic Outcomes and Technology Use for Over 48,000 People with Type 1 Diabetes (2016–2022) from the T1D Exchange Quality Improvement Collaborative
Osagie Ebekozien, Ann Mungmode, Janine Sanchez, et al.
Diabetes Technology & Therapeutics (2023) Vol. 25, Iss. 11, pp. 765-773
Closed Access | Times Cited: 71
National Trends in Sadness, Suicidality, and COVID-19 Pandemic–Related Risk Factors Among South Korean Adolescents From 2005 to 2021
Ho Geol Woo, Sang-Il Park, Hyunju Yon, et al.
JAMA Network Open (2023) Vol. 6, Iss. 5, pp. e2314838-e2314838
Open Access | Times Cited: 49
Prevalence of diabetic retinopathy and vision-threatening diabetic retinopathy in adults with diabetes in China
Xuhong Hou, Limin Wang, Dalong Zhu, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 49
Prevalence and Overlap of Cardiac, Renal, and Metabolic Conditions in US Adults, 1999-2020
John W. Ostrominski, Suzanne V. Arnold, Javed Butler, et al.
JAMA Cardiology (2023) Vol. 8, Iss. 11, pp. 1050-1050
Open Access | Times Cited: 49
Disparities in diabetes prevalence and management by race and ethnicity in the USA: defining a path forward
Saria Hassan, Unjali P. Gujral, Rakale C. Quarells, et al.
The Lancet Diabetes & Endocrinology (2023) Vol. 11, Iss. 7, pp. 509-524
Closed Access | Times Cited: 48
Trends in the Prevalence of Metabolically Healthy Obesity Among US Adults, 1999-2018
Jiangshui Wang, Peng‐Fei Xia, Mengnan Ma, et al.
JAMA Network Open (2023) Vol. 6, Iss. 3, pp. e232145-e232145
Open Access | Times Cited: 42
Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants
Bin Zhou, A. Rayner, Edward W. Gregg, et al.
The Lancet (2024) Vol. 404, Iss. 10467, pp. 2077-2093
Open Access | Times Cited: 36
Antioxidative bioactive glass reinforced injectable hydrogel with reactive oxygen species scavenging capacity for diabetic wounds treatment
Hao Chang, Pengfei Tian, Liuzhi Hao, et al.
Chemical Engineering Journal (2024) Vol. 481, pp. 148768-148768
Closed Access | Times Cited: 23
Vitamin D: Evidence-Based Health Benefits and Recommendations for Population Guidelines
William B. Grant, Sunil J. Wimalawansa, Paweł Płudowski, et al.
Nutrients (2025) Vol. 17, Iss. 2, pp. 277-277
Open Access | Times Cited: 4
Shifts in Metabolic Biomarkers Related to Cardiovascular Disease and Diabetes from 2013 to 2023: A Decade of Change, Including the COVID-19 Era
Caishan Fang, Xiangjun Qi, Tianhui Yuan, et al.
Research Square (Research Square) (2025)
Closed Access | Times Cited: 1
Daytime napping and risk of incident main adverse cardiovascular events and mortality among adults with type 2 diabetes
Xiu Hong Yang, Can Liu, Xin Jiang, et al.
Diabetes Research and Clinical Practice (2025) Vol. 222, pp. 112067-112067
Closed Access | Times Cited: 1
Patient Demographics and Clinical Outcomes Among Type 1 Diabetes Patients Using Continuous Glucose Monitors: Data From T1D Exchange Real-World Observational Study
Daniel J. DeSalvo, Nudrat Noor, Cicilyn Xie, et al.
Journal of Diabetes Science and Technology (2021) Vol. 17, Iss. 2, pp. 322-328
Open Access | Times Cited: 81
Sleep Duration and Risks of Incident Cardiovascular Disease and Mortality Among People With Type 2 Diabetes
Han Han, Ying Wang, Tongtong Li, et al.
Diabetes Care (2022) Vol. 46, Iss. 1, pp. 101-110
Open Access | Times Cited: 65
Causes and risk profiles of mortality among individuals with nonalcoholic fatty liver disease
Peter Konyn, Aijaz Ahmed, Donghee Kim
Clinical and Molecular Hepatology (2022) Vol. 29, Iss. Suppl, pp. S43-S57
Open Access | Times Cited: 55
Social Determinants of Health, Race, and Diabetes Population Health Improvement: Black/African Americans as a Population Exemplar
Felicia Hill‐Briggs, Patti L. Ephraim, Elizabeth A. Vrany, et al.
Current Diabetes Reports (2022) Vol. 22, Iss. 3, pp. 117-128
Open Access | Times Cited: 53
Trends in the Prevalence of Cardiometabolic Multimorbidity in the United States, 1999–2018
Xunjie Cheng, Tianqi Ma, Feiyun Ouyang, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 8, pp. 4726-4726
Open Access | Times Cited: 52
Page 1 - Next Page

Scroll to top